MilDef Group AB (MILDEF)
Stockholm Exchange · Sweden · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 230.70 |
|---|---|
| 52-week range | 110.20 – 254.80 |
| Return, 1 month / 3 months | −6.0% / +0.9% |
| Return, 1 year / 3 years | +22.7% / +234.9% |
| Trend | Uptrend |
| RSI (14) | 48 |
| Volatility (1 year) | 63.6% |
| Worst drawdown (1 year) | -45.0% |
| Average daily value traded | 62.93M SEK |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MilDef Group AB makes rugged computer hardware and electronics for military customers. The company builds laptops, tablets, displays and communications equipment designed to survive harsh field conditions, and it supplies armed forces and defence organisations with these systems. Its work covers both hardware and the integration of electronics into vehicles and command posts. MilDef is based in Sweden and serves defence customers in its home market and abroad.
On this site MilDef Group AB appears as a stock on the Stockholm Exchange (Sweden), code MILDEF, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MilDef Group AB (MILDEF) trades on the Stockholm Exchange in Sweden. It last closed at SEK 230.70 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 221 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.7% and over the last three months it rose 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 27.1% | ||
| From 52-week high | -8.8% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.9% | ||
| 6-month return | 30.0% | ||
| 12-month return, skipping the last month | 30.6% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 63.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.0% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 62.93M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 14 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −8.8% |
|---|---|
| 1 month | −6.0% |
| 3 months | +0.9% |
| 6 months | +30.0% |
| 1 year | +22.7% |
| 3 years | +234.9% |
| 5 years | +414.2% |
Signals
| 50-day / 200-day average | 229.25 / 181.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.20 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | SEK 0.7500 |
| 23 May 2025 | SEK 0.5000 |
| 24 May 2024 | SEK 0.5000 |
| 13 May 2022 | SEK 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.